Month: April 2015

An accompanying article to the Kutner study highlighted the increasing focus placed on diminishing benefits and, in some cases, harms when used in patients with limited life expectancy. Statins are prescribed for only preventive purposes without symptomatic benefit to patients. [...] Continue Reading

Statins are examples of medications in which risks outweigh benefits for patients with limited prognosis.  Jean Kutner and colleagues recently published in JAMA the results of a randomized clinical trial to evaluate the safety, clinical, and cost impact of discontinuing [...] Continue Reading